| Net Cash Provided by (Used in) Operating Activities |
$257,313 |
USD |
-99% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$292,471 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
10,042,249 |
shares |
12% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,721,412 |
USD |
-38% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$2,138,727 |
USD |
-40% |
Q1 2025 |
Q1 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.04 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$21,324,349 |
USD |
-3.5% |
Q4 2024 |
Q3 2025 |
| Additional Paid in Capital |
$251,065,709 |
USD |
13% |
Q3 2025 |
Q3 2025 |